Loading…

Phillips-Medisize, a Molex company, added approximately 140,000 sq. ft. of medical manufacturing space near its existing site in Suzhou, China. The facility will produce drug delivery and medical devices and is slated to begin production in June 2018.
“The expansion confirms the 'Asia for Asia' strategy we announced four years ago, as we continue to see significant growth and demand of customers in this region.”phillipsmedisize.com
Summarized from public sources; check the original articles before acting on it.